L8606 Synthetic implnt urinary 1mlInjectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies
L8606 appears in 10 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross & Blue Shield of Rhode Island, Blue Cross Blue Shield of Massachusetts, Centene, Health Care Service Corporation (BCBS IL, TX, OK, NM, MT).
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Urinary Incontinence (0223) | covered if criteria are met | Jul 16, 2026 | payer document |
| Aetna | Vesicoureteral Reflux Treatment by Endoscopic Injection of Bulking Agents (0534) | covered if criteria are met | Jul 30, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Injectable Bulking Agents For The Treatment Of Urinary And Fecal Incontinence | covered if criteria are met | payer document | |
| Blue Cross & Blue Shield of Mississippi | Periureteral Bulking Agents As A Treatment Of Vesicoureteral Reflux (A.7.01.102) | covered if criteria are met | payer document | |
| Blue Cross & Blue Shield of Mississippi | Prosthetics (L.1.04.401) | covered if criteria are met | payer document | |
| Blue Cross & Blue Shield of Rhode Island | Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence sad | covered if criteria are met | payer document | |
| Blue Cross & Blue Shield of Rhode Island | Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence sad Urinary Incontinence | listed, no stance | payer document | |
| Blue Cross Blue Shield of Massachusetts | Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence (471) | listed, no stance | payer document | |
| Centene | Urinary Incontinence Devices and Treatments Reference Number: CP.MP.142 (CP.MP.142) | covered if criteria are met | Nov 1, 2025 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence (SUR710.008) | listed, no stance | Dec 15, 2025 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux (VUR) (SUR710.022) | listed, no stance | Dec 15, 2025 | payer document |
Prior authorization required or conditional in FL, OH.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.